Corporate Information | Press & Media | For Investors

ThinkGenetic

ThinkGenetic

Finding Patients At Risk for Rare Disease

  • Home
  • Solutions
    • FindEHR™
    • FindSM™
  • Research
    • Medical Publications
    • Technical Research
  • About
    • Team
    • Board
    • Partners
  • News & Events
  • Contact
  • Request a Demo

[Press Release] ThinkGenetic Closes $1.5M Angel Round of Funding

By Ruth O'Keefe, Feb 19, 2019

ThinkGenetic leaders met with former Congressman Billy Tauzin of Louisiana.

LAFAYETTE, La., February 19, 2019 (Newswire.com) – ThinkGenetic, Inc. (www.ThinkGenetic.com), makers of an artificial intelligence-driven SymptomMatcher™​ for genetic disorders, today announced the successful close of its angel round of funding for $1.5M. The final $95,000 investment of five investors was led by entrepreneur and investor, Cian Robinson, Executive Director of the Innovation, Research, and Real Estate Investments division of Lafayette General Health System. Mr. Robinson has been active as a mentor to the company since ThinkGenetic was accepted into the Accelerate South accelerator program in Lafayette, Louisiana, in 2018.

When asked about his relationship with ThinkGenetic Mr. Robinson replied, “Our Health Innovation Fund was capitalized through investments from Lafayette General Health System, via leadership from our Board of Directors and senior leaders. As we seek to make investments, our focus is always on our mission To Restore, Maintain and Improve Health. We believe the future of ThinkGenetic to be bright and of great value to our patients in Acadiana. We look forward to working together to improve health in our communities by being a leader in driving innovation that delivers state-of-the-art outcomes.”

ThinkGenetic plans to use the funds to expand its range of services and personnel, create new partnerships and develop new cutting-edge technology to complement current offerings. In addition, the new relationship with Lafayette General Health System will bring new services to Louisiana including clinical trials and electronic medical record reviews. According to Robinson, “We are excited that our investment in Think Genetic will not only avail our health system and patients of much need genetically focused technologies and services, but also the associated research that comes along with it. Without this relationship, many of our patients have to travel (far) outside of Acadiana to seek clinical trials and treatment. We will now be able to offer these services locally.”

“We’ve had the honor of being considered and accepted to several accelerator programs,” explain ThinkGenetic CEO, Dave Jacob, “The excitement and passion in Lafayette is second to none. We are incredibly excited to close our first seed round and more importantly, to work with the wonderful people of Louisiana and open our third office in Lafayette.”

To stay up to date on the latest business developments of ThinkGenetic and the company’s progress, please visit thinkgenetic.com or follow us on social media using @ThinkGenetic.

Media Contact: 
Ruth O’Keefe
Phone: ‪617.221.6327
Email: ruth@thinkgenetic.com

Source: ThinkGenetic

About Ruth O’Keefe

Ruth anticipates and manages ThinkGenetic's marketing needs in a dynamic environment. She maintains strong engagement with clients and healthcare providers to further the ThinkGenetic mission.

Investor News, News, Partners, Press Releases Acadiana, AccelerateSouth, Billy Tauzin, Cian Robinson, clinicial trials, Dave Jacob, genetic disease, Innovation, Lafayette, Lafayette General Health, Lafayette General Health System, LFHS, Louisiana, Research and Real Estate Investments, ThinkGenetic

Upcoming Events

Oct 17
October 17 - October 21

NSGC Annual Conference 2023

Feb 4
February 4, 2024 - February 9, 2024

WORLDSymposium on Lysosomal Disease Research 2024

Mar 12
March 12, 2024 - March 16, 2024

ACMG Annual Clinical Genetics Meeting 2024

Feb 2
February 2, 2025 - February 7, 2025

WORLDSymposium on Lysosomal Disease Research 2025

Mar 18
March 18, 2025 - March 22, 2025

ACMG Annual Clinical Genetics Meeting 2025

View Calendar

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

  • Solutions
    • FindEHR™
    • FindSM™
  • Resources
    • Contact
    • Research
    • FAQs
  • About ThinkGenetic
    • Team
    • Board
    • Investors
    • Careers
  • Legal
    • Disclaimers
    • Privacy Policy

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.

©2023 ThinkGenetic. All Rights Reserved.